drugset
drugset / Trial / NCT00424372

A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia

NCT00424372 ↗

Phase 3 Completed 126 enrolled Viatris Inc.
Non-randomizedOpen-labelTreatment

Summary

To evaluate the safety of the long-term use of pregabalin.

Timeline

Start
2007-01-12
Primary completion
2008-08-19
Completion
2008-08-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg Oral
Subject Pregabalin Small molecule 300 mg Oral

Indications

postherpetic neuralgia